"Dextroamphetamine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic.
| Descriptor ID |
D003913
|
| MeSH Number(s) |
D02.092.471.683.152.110.200
|
| Concept/Terms |
Dextroamphetamine- Dextroamphetamine
- Dexamphetamine
- Dexamfetamine
- dextro-Amphetamine
- dextro Amphetamine
- d-Amphetamine
- d Amphetamine
Dextroamphetamine Sulfate- Dextroamphetamine Sulfate
- Sulfate, Dextroamphetamine
- Dextro-Amphetamine Sulfate
- Dextro Amphetamine Sulfate
- d-Amphetamine Sulfate
- d Amphetamine Sulfate
|
Below are MeSH descriptors whose meaning is more general than "Dextroamphetamine".
Below are MeSH descriptors whose meaning is more specific than "Dextroamphetamine".
This graph shows the total number of publications written about "Dextroamphetamine" by people in this website by year, and whether "Dextroamphetamine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 3 | 1 | 4 |
| 2003 | 1 | 0 | 1 |
| 2004 | 0 | 1 | 1 |
| 2005 | 2 | 1 | 3 |
| 2006 | 2 | 0 | 2 |
| 2008 | 1 | 0 | 1 |
| 2009 | 2 | 0 | 2 |
| 2011 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2016 | 0 | 1 | 1 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Dextroamphetamine" by people in Profiles.
-
Interventions for the management of fatigue in adults with a primary brain tumour. Cochrane Database Syst Rev. 2022 09 12; 9:CD011376.
-
Adaptive and Behavioral Changes in Kynurenine 3-Monooxygenase Knockout Mice: Relevance to Psychotic Disorders. Biol Psychiatry. 2017 Nov 15; 82(10):756-765.
-
A pilot study of stimulant medication for adults with attention-deficit/hyperactivity disorder (ADHD) who are parents of adolescents with ADHD: the acute effects of stimulant medication on observed parent-adolescent interactions. J Child Adolesc Psychopharmacol. 2014 Dec; 24(10):582-5.
-
D-amphetamine, nicotine, and haloperidol produce similar disruptions in spatial and nonspatial temporal discrimination procedures. Behav Pharmacol. 2011 Apr; 22(2):101-12.
-
ABA chronic dosing of D-amphetamine produces differential drug effects in two variants of a temporal discrimination procedure in pigeons. Behav Pharmacol. 2009 Dec; 20(8):705-19.
-
Effects of acute and chronic d-amphetamine on two variations of a temporal discrimination procedure. Behav Pharmacol. 2009 Oct; 20(7):668-72.
-
Poststroke treatment: lost in translation. Stroke. 2009 Jan; 40(1):8-9.
-
The role of the polymorphic efflux transporter P-glycoprotein on the brain accumulation of d-methylphenidate and d-amphetamine. Drug Metab Dispos. 2006 Jul; 34(7):1116-21.
-
Effects of d-amphetamine on the behavior of pigeons exposed to the peak procedure. Behav Processes. 2006 Feb 28; 71(2-3):268-85.
-
Design, synthesis, and evaluation of the antipsychotic potential of orally bioavailable neurotensin (8-13) analogues containing non-natural arginine and lysine residues. Neuropharmacology. 2005 Dec; 49(8):1149-59.